SUDS3
Sin3 histone deacetylase corepressor complex component SDS3
Also known as: FLJ00052, SAP45, SDS3, SDS3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H7L9
- Gene
- SUDS3
- Ensembl
- ENSG00000111707
- Chromosome
- 12
- Canonical length
- 328 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
SDS3 is a subunit of the histone deacetylase (see HDAC1; MIM 601241)-dependent SIN3A (MIM 607776) corepressor complex (Fleischer et al., 2003 [PubMed 12724404]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
328 residues, UniProt reviewed canonical sequence.
>Q9H7L9|SUDS3
1 MSAAGLLAPA PAQAGAPPAP EYYPEEDEEL ESAEDDERSC RGRESDEDTE DASETDLAKH
61 DEEDYVEMKE QMYQDKLASL KRQLQQLQEG TLQEYQKRMK KLDQQYKERI RNAELFLQLE
121 TEQVERNYIK EKKAAVKEFE DKKVELKENL IAELEEKKKM IENEKLTMEL TGDSMEVKPI
181 MTRKLRRRPN DPVPIPDKRR KPAPAQLNYL LTDEQIMEDL RTLNKLKSPK RPASPSSPEH
241 LPATPAESPA QRFEARIEDG KLYYDKRWYH KSQAIYLESK DNQKLSCVIS SVGANEIWVR
301 KTSDSTKMRI YLGQLQRGLF VIRRRSAALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SUDS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 24 nTPM
- thyroid gland: 20 nTPM
- esophagus: 20 nTPM
- skin: 19 nTPM
- tonsil: 18 nTPM
- salivary gland: 18 nTPM
Single-cell type
- oocytes: 327 nCPM
- early spermatids: 269 nCPM
- late primary spermatocytes: 202 nCPM
- esophageal apical cells: 179 nCPM
- esophageal suprabasal cells: 119 nCPM
- respiratory ciliated cells: 108 nCPM
Immune cell
- neutrophil: 13 nTPM
- memory B-cell: 8.8 nTPM
- naive B-cell: 8.4 nTPM
- plasmacytoid DC: 6.8 nTPM
- naive CD4 T-cell: 6.4 nTPM
- MAIT T-cell: 6.1 nTPM
Brain region
- cerebral cortex: 34 nTPM
- midbrain: 33 nTPM
- pons: 32 nTPM
- basal ganglia: 30 nTPM
- amygdala: 29 nTPM
- hippocampal formation: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.94
- DepMap mean gene effect
- -0.73
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- chromatin remodeling
- negative regulation of cell migration
- negative regulation of DNA-templated transcription
- negative regulation of stem cell population maintenance
- negative regulation of transcription by RNA polymerase II
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of stem cell population maintenance
- substantia nigra development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SUDS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SUDS3 as an antibody target. Whether an autoantibody or antibody against SUDS3 could matter depends on whether native SUDS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SUDS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SUDS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...